Comparison of Three Cellular Assays to Predict the Course of CMV Infection in Liver Transplant Recipients
To estimate protection from <i>cytomegalovirus</i> (CMV) replication after solid organ transplantation, CMV serology has been considered insufficient and thus CMV immunity is increasingly assessed by cellular in vitro methods. We compared two commercially available IFN-γ ELISpot assays (...
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
MDPI AG
2021-01-01
|
| Saila: | Vaccines |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2076-393X/9/2/88 |